Home › Funds › Regal Partners Ltd › RPRX

Regal Partners Ltd position in RPRX

ROYALTY PHARMA PLC · Health Care

Regal Partners Ltd reported holding 2,447,879 shares of RPRX (ROYALTY PHARMA PLC) in its Q2 2026 13F filing — a position valued at US$137.3M, representing 7.58% of its reported portfolio and ranking #4 among its reported holdings. Regal Partners Ltd has disclosed RPRX holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

Latest position (Q2 2026)2.45M sh
Reported value held$137.25M
Portfolio Weight7.58%
First reportedQ1 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Regal Partners Ltd's RPRX position evolved

Regal Partners Ltd first disclosed a stake in RPRX in Q1 2024 at 959,827 shares (US$29.1M). The position peaked in Q2 2026 at 2,447,879 shares, worth US$137.3M. Across 10 filings, Regal Partners Ltd increased the stake 4 time(s), trimmed it 3 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 2,447,879 shares valued at US$137.3M — a reduction of -176,593 shares quarter over quarter.. Notable position changes include a 84% increase in Q4 2025 (shares rose 24% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 959.83K $29.15M New
Q2 2024 1.18M $31.05M Add
Q3 2024 1.18M $33.31M Hold
Q4 2024 1.44M $36.63M Add
Q1 2025 1.44M $44.70M Hold
Q2 2025 1.35M $48.47M Reduce
Q3 2025 1.44M $50.63M Add
Q4 2025 2.64M $102.04M Add
Q1 2026 2.62M $125.90M Reduce
Q2 2026 2.45M $137.25M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RPRX and 13F data

RPRX (ROYALTY PHARMA PLC) is a Health Care company. 49 other funds we track also report a position in RPRX — the largest reported positions include Swedbank AB (US$601.4M), Baillie Gifford & Co (US$561.6M), Caledonia (Private) Investments Pty Ltd (US$323.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RPRX

All RPRX fund holders →

FAQ

How long has Regal Partners Ltd held RPRX?

Regal Partners Ltd has disclosed RPRX holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

What is Regal Partners Ltd's current position in RPRX?

As of Q2 2026, Regal Partners Ltd holds 2.45M shares of RPRX (ROYALTY PHARMA PLC), valued at $137.25M, representing 7.58% of its reported portfolio and ranking #4.

Has Regal Partners Ltd been buying or selling RPRX?

In the latest 13F filing (Q2 2026), Regal Partners Ltd reduced its position in RPRX. The position peaked in Q2 2026 at 2.45M shares.

Which other funds hold RPRX?

Other major institutional holders of RPRX include Swedbank AB, Baillie Gifford & Co, Caledonia (Private) Investments Pty Ltd, among 49 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.